Treatment of Malignant Gliomas with Surgery, Intra-arterial Infusions of 1-(2-Hydroxyethyl)chloroethylnitrosourea, and Radiation Therapy: A Phase II Study

Author:

Fauchon François1,Davila Luis2,Chatellier Gilles3,Fohanno Denis4,Philippon Jacques4,Rey Alain5,Chiras Jacques2,Poisson Michel6,Delattre Jean Yves1,Delattre Jean Yves6

Affiliation:

1. Departments of Radiation Therapy, Hôpital Beaujon, Paris, France

2. Neuroradiology Hôpital Beaujon, Paris, France

3. Biostatisties Hôpital Beaujon, Paris, France

4. Neurosurgery Hôpital Beaujon, Paris, France

5. Groupe Hospitalier Pitié-Salpêtrière, and Department of Neurosurgery, Hôpital Beaujon, Paris, France

6. Neurology Hôpital Beaujon, Paris, France

Abstract

Abstract Forty patients with malignant supratentorial gliomas were treated with surgery, intra-arterial infusions of 1-(2-hydroxyethyl) chloroethylnitrosourea, and radiation therapy. The median duration of survival was 12 months: it differed according to the histological subtype (over 30 months for patients with anaplastic astrocytomas or anaplastic oligoden-droglioma and 10.5 months for glioblastoma; P= 0.0025). Serious complications of monocular blindness and leukoencephalopathy were observed in four patients (10%).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art;Frontiers in Oncology;2022-09-23

2. Intraarterial Chemotherapy;Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy;2018

3. Endovascular therapies for malignant gliomas: Challenges and the future;Journal of Clinical Neuroscience;2016-04

4. Intra-Arterial Chemotherapy;Handbook of Brain Tumor Chemotherapy;2006

5. Intra-arterial chemotherapy of primary brain tumors;Current Treatment Options in Oncology;2005-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3